Click on the tab to search across Lilly for additional information
Cymbalta in MDD

Cymbalta in MDD

Multidimensional Aspects of Depression

Major depressive disorder (MDD) has a broad range of symptoms, including depressed mood, loss of energy, feelings of guilt, lack of energy, decreased concentration, changes in appetite, sleep or psychomotor activity, and recurrent thoughts of death or suicidality. Other associated symptoms may also include anxiety or phobias, bodily aches and pains, and irritability.1 Treating MDD can be complex. Patients may present with emotional and somatic symptoms.

Cymbalta Demonstrated Broad Efficacy, Safety and Tolerability, and Once-daily Dosing in MDD

References:

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, Text Revision; Washington, DC: American Psychiatric Association, 2000.
  2. Perahia DG, et al. Br J Psychiatry. 2006;188:346-353.
  3. Data on file, Lilly Research Laboratories: CYM20060101A.
  4. Fava M, et al. J Clin Psychiatry. 2004;65(4):521-530.
  5. Cymbalta full Prescribing Information, 2008.

Cymbalta for Fibromyalgia

Cymbalta is indicated for the management of fibromyalgia.

Formulary Access Finder

Cymbalta has been added to the Anthem Blue Cross Blue Shield National Preferred Formulary.

Get more information about the formulary access for Cymbalta. Download PDF files of insurance providers covering Cymbalta in your state.

Thought Leader Podcasts

Listen to peers and experts discuss the latest advances in diagnosis and treatment for MDD, GAD, DPNP, and fibromyalgia.
Listen to the podcasts now.